Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
United Press International - July 1, 2009
Officials at Sumagen Co. Ltd., the manufacturer of the vaccine, said they have submitted an investigational new drug application to the U.S. Food and Drug Administration to begin Phase 1 human trials for its SAV001-H AIDS vaccine.
The vaccine was developed by Professor Chil-Yong Kang who, with Sumagen, has completed safety and immunogenicity studies on animals.
University officials said Sumagen Canada has secured patents for the vaccine in more than 70 nations, including the United States, the European Union and Korea. According to the firm, animal testing has resulted in good antibody reactions in immunology tests, with no adverse effects or safety risks.
"The Phase l clinical trials, if approved, will double check the safety of the vaccine using HIV positive volunteers," the university said in a statement. "The second stage -- Phase ll trials -- would then assess the immunogenicity of the vaccine."
090701
UP090615
Copyright © 2009 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .